# Epothilone in Recurrent Glioblastoma Patients

> **NCT00397072** · PHASE2 · COMPLETED · sponsor: **Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta** · enrollment: 15 (actual)

## Conditions studied

- Glioblastoma

## Interventions

- **DRUG:** ZK 219477

## Key facts

- **NCT ID:** NCT00397072
- **Lead sponsor:** Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-06
- **Primary completion:** 2008-03
- **Final completion:** 2008-12
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2014-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00397072

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00397072, "Epothilone in Recurrent Glioblastoma Patients". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00397072. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*